medical developments international limited annual report

Looks you are already a member. 0000236586 00000 n 0000249634 00000 n 0000255508 00000 n 0000003817 00000 n 0000236695 00000 n 0000242900 00000 n For the effect of fees on your cumulative returns, please see our report 0000236087 00000 n First name is required. Product disclosure statements for financial products offered through InvestSMART can be downloaded from this website or obtained by contacting 1300 880 160. # InvestSMART Portfolio performance figures are after management and admin fees excl. 0000008817 00000 n 0000005272 00000 n 0000243935 00000 n Email is required.

The Company manufactures Penthrox, a fast-acting trauma & emergency pain relief product. 'Eureka Report' : 'Intelligent Investor' }} 15-day trial.The email address you entered is registered with InvestSMARTWe have sent you an email with the details of your registration.

0000011563 00000 n

You must accept the terms and conditions. 0000004541 00000 n 0000237777 00000 n

Fee data may not include all costs being charged such as platform and adviser fees. 0000237702 00000 n

Password is required. 0000252554 00000 n The peer calculation is inclusive of admin and management fees; excludes brokerage and no withdrawals have been made. MVP is into emergency pain relief and respiratory products. does not include fees charged within any ETF held in this portfolio, estimated to be approximately 0.18% (indirect cost ratio). Email must be a valid email. 0000237885 00000 n

0000241806 00000 n MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED Stock | … Medical Developments International Limited (MVP) is an Australia-based company delivering emergency medical solutions dedicated to improving patient outcomes.

0000240637 00000 n 0000236508 00000 n MVP is into emergency pain relief and respiratory products. View our Please enter your email address below to request a new passwordDISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. 0000243428 00000 n 0000008122 00000 n %PDF-1.7 %���� 459 0 obj <> endobj xref 459 53 0000000016 00000 n Email is required. Medical Developments International Limited ABN 14 106 340 667 4 Caribbean Drive Scoresby Victoria 3179 Australia Postal Address PO Box 9004 Scoresby Victoria 3179 Australia Telephone +61 3 9547 1888 Fax +61 3 9547 0262 Web www.medicaldev.com 17 August, 2018 ANNUAL REPORT Pursuant to listing rule 4.3A, please attached Medical Developments International Limited’s audited You should consider the product disclosure statement before making a decision about a product. "FREE" : "$" + t.Cost.toFixed(2) }} InvestSMART cannot determine whether or not franking has been included, nor if dividends have been reinvested. 0000002455 00000 n

0000236153 00000 n This may not include all funds available for retail investment in Australia. 0000249286 00000 n {{ t.Cost === 0 ?

trailer<<1f3e2715e02d14041e9441ea2e5f7d73>]>> startxref 0 %%EOF 460 0 obj <>>>/Lang(en-US)/Metadata 451 0 R/Names 461 0 R/Outlines 387 0 R/Pages 452 0 R/Type/Catalog/ViewerPreferences<>>> endobj 511 0 obj < For more information about fees and costs, please see the 0000251660 00000 n 0000002419 00000 n

Fees are calculated by Morningstar as the average over 10 years. 0000243344 00000 n 0000235195 00000 n 0000237289 00000 n Password is required. Copyright © 1999-2020 InvestSMART Financial Services Pty Ltd. All rights reserved | Australian Financial Services Licensee: AFSL # 226435 | ABN 70 089 038 531 | 0000002983 00000 n Only funds with > three year returns were included in any fee comparison, and were compared to Morningstar's nominated benchmark. Whilst every care has been taken in producing these numbers, InvestSMART does not guarantee the accuracy of the figures produced in the table. 0000001655 00000 n Read detailed company information including earnings, capital structure, cashflow & historical financials.

Email must be a valid email.

Mobile phone number is invalid. 0000236175 00000 n Please enter your password to proceed It may take a few minutes to update your subscription details, during this time you will not be able to view locked content. 0000237355 00000 n 0000241916 00000 n Email is required. $0.13 0000252072 00000 n 0000235975 00000 n ^^ 557 Buy recommendations published by Intelligent Investor between 1 June 2001 and 30 June 2019 were independently verified by EY, as per the All indications of performance returns are historical and cannot be relied upon as an indicator for future performance. 0000237381 00000 n * InvestSMART's capped Management Fee (capped at $451p.a.) Last name is required. 0000001453 00000 n Please untick this box when using a public or shared device

4 Medical Developments International Limited Annual Financial Report 2018 5 United States of America Recent developments in the USA around opioid addiction and abuse make the clinical need and market opportunity for Penthrox® more urgent. The Company manufactures Penthrox, a fast-acting trauma & emergency pain relief product.